E Khatamzas1, H Hughes, K A Grant, J McLauchlin, I C J W Bowler. Show Affiliations » 1. Department of Microbiology, John Radcliffe Hospital, Oxford OX3 9DU, UK. elham.khatamzas@imm.ox.ac.uk
Abstract
Mesh: See more » AgedAmoxicillin/therapeutic useAnti-Bacterial Agents/therapeutic useAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useDietFemaleHumansImmunocompromised HostImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/therapeutic useListeria monocytogenes/isolation & purificationListeriosis/epidemiologyListeriosis/etiologyMalePrevalenceTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Anti-Bacterial AgentsAntibodies, MonoclonalImmunosuppressive AgentsTumor Necrosis Factor-alphaAmoxicillin
Year: 2009 PMID: 20042433 DOI: 10.1093/qjmed/hcp181
Source DB: PubMed Journal: QJM ISSN: 1460-2393